血液透析长期血管通路及并发症处理被引量：16

在线阅读下载PDF

导出

摘要血液透析是终末期肾病患者赖以生存的重要肾脏替代治疗手段之一，而良好的血管通路是血液透析得以顺利进行的前提和保障，近年来随着血液透析技术、设备的不断完善，糖尿病、高血压、肥胖等疾病发病率的不断上升，终末期肾病患者血液透析龄的不断延长，对能够满足长期维持透析血管通路的要求越来越高，不但要有较高的通畅率、较长的使用率和较低的并发症发生率，还要有一定的美观性，尽量减轻透析患者的心理负担，提高他们的生存质量和生活质量。

作者任志龙杨定平

机构地区武汉大学人民医院肾内科

出处《临床肾脏病杂志》 2015年第9期516-519,共4页 Journal Of Clinical Nephrology

关键词血液透析技术长期血管通路并发症处理肾脏替代治疗并发症发生率肾病患者疾病发病率维持透析

分类号 R692.5 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献16

1郑月宏.血液透析动静脉瘘建立的策略和复杂情况的处理[J].临床外科杂志,2009,17(5):299-300. 被引量：4
2Chung S, Choi DE, Na KR, et al. Rupture of an infectious pseudoaneurysm of the aortic arch in an end-stage renal failure patient with chronic hemodialysis[J]. Clin Nephrol, 2015, 84 (7) : 39-43.
3王玉柱,叶朝阳,金其庄.中国血液透析用血管通路专家共识(第1版)[J].中国血液净化,2014,13(8):549-558. 被引量：586
4梅长林,叶朝阳.血液透析血管通路及其并发症处理.首届中国肾脏内科医师年会会议论文,2008.119-123.
5Donati G, Cianciolo G, Mauro R, et al. PTFE grafts versus tunneled cuffed catheters for hemodialysis: which is the second choice when arteriovenous fistula is not feasible?[J]. Artif Or gans, 2015, 39(2): 134-141.
6Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis, 2006, 48(Suppl 1) : S248- S273.
7Stojceva-Taneva O, Selim G. Vascular access in hemodialyis patients-registry data[J]. Hippokratia, 2014, 18 (3) : 209- 211.
8Mufty H, Claes K, Heye S, et al. Proactive surveillance ap- proach to guarantee a functional arteriovenous fistula at first dialysis is worth[J]. J Vasc Access, 2015, 16(3): 183-188. S.
9ousa CN, Apestolo JL, Figueiredo MH, et al. Construction and validation of a scale of assessment of self-care behaviors with arteriovenous fistula in hemodialysis[J]. Hemodial Int, 2015, 19(2): 306-313.
10王云燕,傅丽丽,毛静,封蕾,黄龙,李云姝,周玉婷,李丽.血液透析患者动静脉瘘狭窄机制和防护进展[J].现代临床护理,2014,13(12):66-70. 被引量：2

二级参考文献32

1Besarab A.Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis [J] .J Am Soc Nephrol,2008,19 (9) :1629-1633.
2Basile C, Lomonte C. Pro: The arteriovenous fistula is a blessing of God [J]. Nephrol Dial Transplant, 2012,27 (10) :3752-3756.
3Voormolen EH,Jahrome AK,Bartels LW,et al. Nonmaturation of arm arteriovenous fistulas for hemodialysis access: A systematic review of risk factors and results of early treatment [J ] .J Vasc Surg, 2009,49 (5) :1325-1336.
4Smith GE,Gohil R, Chetter IC.Factors affecting the patency of arteriovenous fistulas for dialysis access [J]. J Vasc Surg,2012,55 (3):849-855.
5Rose DA,Sonaike E,Hughes K.Hemodialysis access[J]. Surg Clin North Am, 2013,93 (4):997-1012.
6Erkut B, Unltl Y, Ceviz M, et al.Primary arteriovenous fistulas in the forearm for hemodialysis:Effect of miscellaneous factors in fistula patency [J] .Ren Fail, 2006,28 (4) :275-281.
7Mima A.Hemodialysis vascular access dysfunction: Molecular mechanisms and treatment [J] .Ther Apher Dial, 2012,16 (4) :321-327.
8Allon M, Litovsky S, Young C J, et al.Medial fibrosis, vascular calcification,intimal hyperplasia, and arteriovenous fistula maturation [J]. Am J Kidney Dis, 2011,58 (3) :437-443.
9Liang A,Wang Y, Han G, et al.Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula [J] .Am J Physiol Renal Physiol, 2013,304 (12) :F1413-1420.
10Ghiadoni L, Cupisti A, Huang Y,et al.Endothelial dysfunction and oxidative stress in chronic renal failure [J] .J Nephrol, 2004,17 (4) :512-519.